Correct. All this stuff will take at least 2x longer than
Correct. All this stuff will take at least 2x longer than just the math of ideal dates. It was the same for CD10 and 12. We all knew last patient was dosed then it was way way past 28 days. We had to "lock" the data, blah blah. Plus i'm guessing we have to deal with Brazil issues that we didnt have to deal with for CD10/12.
We will all probably gnash our teeth with the debate about interim analysis too. I mean we are so close to full enrollment we should just keep going to really prove to the world about LL. Well maybe not... NP is an idiot for having 40% interim when we all knew it would fill super fast. NP is a dummy for having such a large trial in a foreign country that would take forever to fill. More taste, less filling.
We will probably send stuff to them in spanish then get ignored until we realize we had to send in Portuguese. Plus the email will get stuck in spam, then somehow put in the archive folder unknowingly. I know i sent it but it isnt anywhere i can find it. I mean how can i blame NP for losing an email when its common practice for me. Maybe LL will prove dementia/alzheimer's applicable, or maybe just enough to help me remember my sunglasses are on my head and i left my wallet in the console.
LH. Everyone knows the real money is in LH and if we had only spent more time and gotten LH P3 going we would be in a better spot than chasing severe and critical. I mean NP should have known that covid cases would drop through the floor in brazil. i mean we all saw it, how could he have been so dumb. If only they had done LH in brazil we would be approved by now.
What is the status of the cancer BTD? We have awesome results! Its a slam dunk. Expect variations of this in the coming weeks.
HIV BLA. I think this is getting left on the table simply for us to have something to discuss when we get bored of covid. I mean if it was all done we'd all be swimming in the proverbial respert scrooge mcduck pond of coins and it wouldnt matter.
I would really like to see a reinvigoration of the GvHD. I mean thats been pretty quiet, with the pause of the study. Could someone volunteer to beat this drum and really make some noise so we can have something else to grouse about?
NASH. I really havent spent a bunch of time on this one and dont really understand what the big fuss its. I'm kind of a fatty, so maybe i have a fatty liver. Hopefully LL is better than a keto diet, because i'm kind of a bread guy.
I'm kinda hoping that LL has indications for general inflammation. Ohms list has a bunch of 'itis's and 'osis's on it. My damn plantar fasciitis could maybe use a shot of LL. Also my son who pitches gets a little tendonitis because he doesnt do his core exercises. Both my son and i could continue to be lazy bums and just get an occasional shot of LL and let me live the way i want.
2
3
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
HITRUST i1 Certification: The Gold Standard in Security For a world increasingly reliant on digital infrastructure, cybersecurity certification is no longer just a badge of honor; it's a cornerstone of trust. Dentistry.One nailed this down by bagging that coveted HITRUST i1 certification. When folks talk about securing data, HITRUST might as well be speaking gospel. We're...
Continue Reading
Change of Guard in Cardiac Health at Karoo Here's a move that might shake things up in the healthtech sector: Karoo Health just snagged Angela "Angie" Breton as their new Chief Commercial Officer. It's like putting a seasoned captain at the helm right before setting sail on uncharted waters. Breton's not just any captain—she's got a hefty 25 years of experience...
Continue Reading
A Global Stage for Pet Nutrition Science The folks over at the Purina Institute are back in the spotlight as they gear up to throw their weight behind the 51st World Small Animal Veterinary Association (WSAVA) Congress in Warsaw, Poland. Set for October 13-15, 2026, this isn’t just another event—they're bringing some serious clout with their 'Food for Thought'...
Continue Reading
NYSE Texas: Carving a Niche The notion of 'Y'all Street' might seem like a gimmick, but NYSE Texas is pushing a serious agenda with its newly released white paper, 'NYSE Texas and the Reshaping of U.S. Capital Markets.' This is no small feat. Texas is already housing 235 NYSE-listed companies, boasting a colossal combined worth of $4.8 trillion. With 130 of these firms...
Continue Reading
Fresh Leadership at Northern Jet Well, if you didn’t see this coming, you’ve been snoozing on the tarmac. Northern Jet, no stranger to the skies after three decades, just roped in Matthew Harris as their new CEO from October 2, 2026. They're pulling in this hotshot with more than 25 years riding the turbulence of private aviation. And listen to this: his marching...
Continue Reading
Adams' Provocative Debut Asks Timeless Questions Sometimes life throws a philosophical curveball, and that's exactly what John C. Adams has done with his debut novel, The Third Phase. This isn't your average political yarn—it's an intricate tapestry intertwining political intrigue, deep spiritual inquiry, and hearty doses of classic philosophy. A Whirlwind Journey...
Continue Reading
Peering Into CNG's Latest Innovation Charter Next Generation (CNG) just threw down a hefty gauntlet with its launch of next-gen machine-direction-oriented polyethylene (MDO-PE) solutions. They're pushing the envelope on what recycle-ready packaging can do, folks. Let's not mince words—other players in the field better have their game faces on. This ain't just another...
Continue Reading
A Missed Opportunity for Community Banks It's a classic tale: community banks sleepwalking while big players snatch up low-hanging fruit right in their own backyards. According to the latest report by Cornerstone Advisors, commissioned by Teslar Software, these banks are essentially leaving $106 billion on the table when it comes to consumer lending. That's not just chump...
Continue Reading
Visionary Steps Toward a Brighter Future No two words could describe the task that Cure Blindness Project is tackling this year: vision and action. Marking World Sight Day on October 8, they plan to usher in 770,000 eye screenings across Asia, Africa, and the Caribbean. These initiatives aren't just numbers—they're a colossal step toward lifting the veil of avoidable...
Continue Reading
The Urgency of Liver Cancer Awareness Death doesn’t wait, does it? When liver cancer is the villain in question, every moment becomes precious because this beast doesn’t roar until it’s too late. Here we are in 2026, staring at nearly 31,000 annual deaths in the U.S. alone. But hope flickers with a new congressional resolution aiming to slap a bright spotlight on...
Continue Reading
Top 5 Most Recently Viewed Articles
Total Voting Rights and Capital Overview Albion Technology & General VCT PLC In accordance with the Disclosure Guidance and Transparency Rule 5.6.1, Albion Technology & General VCT PLC, commonly known as the "Company," is pleased to share an update regarding its total voting rights and issued share capital. Current Share Capital Details Recently, the Company has provided...
Continue Reading
Gilat Satellite Networks Showcases Innovations at APEX/IFSA Conference Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT) is making waves in the aviation sector with its innovative technology for in-flight connectivity (IFC). People attending the upcoming APEX/IFSA Global Expo will gain valuable insights into how Gilat is transforming passenger experiences through...
Continue Reading
Bladex's Fourth Quarter 2024 Conference Call Invitation Banco Latinoamericano de Comercio Exterior, S.A. (NYSE: BLX) is excited to invite all interested parties to engage in its upcoming conference call. This session will focus on the bank's performance and results for the fourth quarter of 2024. It's a fantastic opportunity for investors and analysts to gain insights...
Continue Reading
VR UniBlock Inc. launched its pre-production VERRA Series chipset back in late 2024, boasting a wireless transmission latency of less than 0.3ms—an impressive feat for any semiconductor company. But while traders might have been buzzing about this ‘game-changing’ tech, the real questions linger on how it’ll hold up against market demands and competition come 2025....
Continue Reading
LEPAS Shines at the Indonesia International Auto Show In April of this year, Chery Group introduced a new brand, LEPAS, launching its ambitious plan for a global audience eager for refined lifestyle experiences. This significant step in their international strategy marks LEPAS's debut at the Indonesia International Auto Show, which commences shortly. A Bold Step into...
Continue Reading